Repeated infusions of anti-TNF-alpha chimeric antibody (cA2) maintain remission in refractory Crohn's disease

被引：0
|
作者：
DHaens, G
Rutgeerts, P
vanDeventer, SJH
Present, DH
Mayer, L
Hanauer, SB
Braakman, TAJ
DeWoody, KL
Schaible, TF
Targan, SR
机构：
[1] UZ GASTHUISBERG,LOUVAIN,BELGIUM
[2] AMC,AMSTERDAM,NETHERLANDS
[3] UNIV CHICAGO,CHICAGO,IL 60637
[4] CENTOCOR INC,MALVERN,PA 19355
[5] CEDARS SINAI MED CTR,LOS ANGELES,CA 90048
来源：
GUT | 1997年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A68 / A69
页数：2
相关论文
共 50 条
  • [21] Successful treatment of oral Crohn's disease by anti-TNF-alpha dose escalation - a case report
    Bokemeyer, Arne
    Tentrop, Nicolas
    Barth, Peter J.
    Lenze, Frank
    Hengst, Karin
    Kleinheinz, Johannes
    Bettenworth, Dominik
    BMC GASTROENTEROLOGY, 2018, 18
  • [22] Successful treatment of oral Crohn's disease by anti-TNF-alpha dose escalation - a case report
    Arne Bokemeyer
    Nicolas Tentrop
    Peter J. Barth
    Frank Lenze
    Karin Hengst
    Johannes Kleinheinz
    Dominik Bettenworth
    BMC Gastroenterology, 18
  • [23] Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-alpha Therapy With Infliximab for Crohn's Disease
    Kamel, Amir Y.
    Concepcion, Orestes
    Schlachterman, Alexander
    Glover, Sarah
    Forsmark, Christopher Y.
    ACG Case Reports Journal, 2016, 3 (03): : 187 - 189
  • [24] Anti-TNFα monoclonal antibody (cA2) produces endoscopic healing in patients with treatment-resistant, active Crohn's disease.
    D'Haens, GR
    van Deventer, SJH
    Van Hogezand, R
    Chalmers, DM
    Braakman, TAJ
    Schaible, TF
    Rutgeerts, PJ
    GASTROENTEROLOGY, 1998, 114 (04) : A964 - A964
  • [25] MONOCLONAL ANTI-TNF-ALPHA ANTIBODY AS A PROBE OF PATHOGENESIS AND THERAPY OF RHEUMATOID DISEASE
    MAINI, RN
    ELLIOTT, MJ
    BRENNAN, FM
    WILLIAMS, RO
    CHU, CQ
    PALEOLOG, E
    CHARLES, PJ
    TAYLOR, PC
    FELDMANN, M
    IMMUNOLOGICAL REVIEWS, 1995, 144 : 195 - 223
  • [26] CLINICAL-RESPONSE OF RHEUMATOID-ARTHRITIS (RA) TO ANTI-TNF-ALPHA (CA2) MONOCLONAL-ANTIBODY (MAB) IS RELATED TO ADMINISTERED DOSE AND PERSISTENCE OF CIRCULATING ANTIBODY
    MAINI, RN
    ELLIOT, MJ
    LONGFOX, A
    FELDMANN, M
    KALDEN, JR
    ANTONIO, C
    SMOLEN, JS
    LEEB, B
    BREEDVELD, FC
    MACFARLANE, JD
    BIJL, H
    WOODY, JN
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 200 - 200
  • [27] Anti-TNF alpha therapy (cA2) in Crohn's disease, increases synthesis of IFN gamma by stimulated CD4+-lymphocytes.
    Meenan, J
    deSmit, O
    Spaans, J
    Hommes, DW
    Obradov, D
    Shealy, DJ
    Tytgat, GNJ
    vanDeventer, SJH
    GASTROENTEROLOGY, 1997, 112 (04) : A1039 - A1039
  • [28] Amicrobial Pustulosis-Like Rash in a Patient with Crohn's Disease under Anti-TNF-Alpha Blocker
    Lee, Haur Yueh
    Pelivani, Nedzmidin
    Beltraminelli, Helmut
    Hegyi, Ivan
    Yawalkar, Nikhil
    Borradori, Luca
    DERMATOLOGY, 2011, 222 (04) : 304 - 310
  • [29] Changes in Hepcidin and Hemoglobin After Anti-TNF-alpha Therapy in Children and Adolescents With Crohn Disease
    Atkinson, Meredith A.
    Leonard, Mary B.
    Herskovitz, Rita
    Baldassano, Robert N.
    Denburg, Michelle R.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (01): : 90 - 94
  • [30] Year 1997: Short-term study of the cA2 chimeric monoclonal antibody directed against human tumour necrosis factor-alpha for Crohn's disease
    Gomollon, Fernando
    Marin-Jimenez, Ignacio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (07): : 379 - 380
12345